J Grosjean1, L Trapes2, S Hantz1, C Mengelle3, B Virey4, F Undreiner5, V Messager2, F Denis6, B Marin7, S Alain8. 1. CHU Limoges, Bacteriology-Virology Department, Limoges, France; National Reference Center for Cytomegaloviruses, Limoges, France; Univ Limoges, Inserm UMR 1092, Faculté de Médecine, Limoges, France. 2. CHU Limoges, Pediatric Emergency Unit, Limoges, France. 3. CHU Toulouse, Virology Department, Toulouse, France. 4. Pediatrician, Association Française de Pédiatrie Ambulatoire, Dijon, France. 5. Pediatrician, Association Française de Pédiatrie Ambulatoire, Strasbourg, France. 6. CHU Limoges, Bacteriology-Virology Department, Limoges, France; Univ Limoges, Inserm UMR 1092, Faculté de Médecine, Limoges, France. 7. CHU Limoges, Unité Fonctionnelle de Recherche Clinique et de Biostatistique, Limoges, France. 8. CHU Limoges, Bacteriology-Virology Department, Limoges, France; National Reference Center for Cytomegaloviruses, Limoges, France; Univ Limoges, Inserm UMR 1092, Faculté de Médecine, Limoges, France. Electronic address: sophie.alain@unilim.fr.
Abstract
BACKGROUND: Cytomegalovirus (CMV) infection is the most important cause of congenital viral infection in developed countries. In utero transmission occurs at higher rates in seronegative women during primary infection, especially those in contact with young children in day-care centers (DCC). Nevertheless data on variability of CMV excretion among children in French DCCs are lacking, and are important for public health planning. OBJECTIVES: Our main objective was to assess the feasibility of a salivary sample in DCCs in order to study CMV excretion among toddlers. Our secondary aims were to assess prevalence of CMV excretion in children attending Hospital Emergency Unit (EU) in comparison with various types of DCCs and to validate the analytical chain for collected specimens. STUDY DESIGN: Excretion of CMV in saliva was quantified using a real-time PCR assay in children aged from 3 months to 6 years old in EU and in DCC, with gB, gH and gN genotypes determined in infected children. Salivary sampling was performed using small sponges placed into a DNA conservation medium. Socio cultural and medical information were collected from attending parents. RESULTS: A total of 625 children were included, with 256 from six DCCs and 369 from one EU. In DCCs, the acceptability of the procedure was 87.3% (95%CI 78.5-96.2) amongst parents and children, and in the EU, acceptability was higher at 97.6% (95%CI 95.5-98.9). CMV shedding overall prevalence was 21.7% (95%CI 17.6-26.2), with CMV shedding prevalence in DCCs of 51.9% (95%CI 22.8-81.1). CONCLUSION: We validated the feasibility and acceptability of measuring CMV shedding in the saliva of French toddlers. The discrepancy between CMV infection rates in day care centers and in the general population (as sampled in the EU) indicates the need for a further study to determine risk factors and shedding levels in the DCC population.
BACKGROUND:Cytomegalovirus (CMV) infection is the most important cause of congenital viral infection in developed countries. In utero transmission occurs at higher rates in seronegative women during primary infection, especially those in contact with young children in day-care centers (DCC). Nevertheless data on variability of CMV excretion among children in French DCCs are lacking, and are important for public health planning. OBJECTIVES: Our main objective was to assess the feasibility of a salivary sample in DCCs in order to study CMV excretion among toddlers. Our secondary aims were to assess prevalence of CMV excretion in children attending Hospital Emergency Unit (EU) in comparison with various types of DCCs and to validate the analytical chain for collected specimens. STUDY DESIGN: Excretion of CMV in saliva was quantified using a real-time PCR assay in children aged from 3 months to 6 years old in EU and in DCC, with gB, gH and gN genotypes determined in infected children. Salivary sampling was performed using small sponges placed into a DNA conservation medium. Socio cultural and medical information were collected from attending parents. RESULTS: A total of 625 children were included, with 256 from six DCCs and 369 from one EU. In DCCs, the acceptability of the procedure was 87.3% (95%CI 78.5-96.2) amongst parents and children, and in the EU, acceptability was higher at 97.6% (95%CI 95.5-98.9). CMV shedding overall prevalence was 21.7% (95%CI 17.6-26.2), with CMV shedding prevalence in DCCs of 51.9% (95%CI 22.8-81.1). CONCLUSION: We validated the feasibility and acceptability of measuring CMV shedding in the saliva of French toddlers. The discrepancy between CMV infection rates in day care centers and in the general population (as sampled in the EU) indicates the need for a further study to determine risk factors and shedding levels in the DCC population.
Authors: Cody S Nelson; Ilona Baraniak; Daniele Lilleri; Matthew B Reeves; Paul D Griffiths; Sallie R Permar Journal: J Infect Dis Date: 2020-03-05 Impact factor: 5.226
Authors: Johanna Stranzinger; Agnessa Kozak; Benjamin Schilgen; Diana Paris; Thomas Nießen; Lutz Schmidt; Andreas Wille; Norbert L Wagner; Albert Nienhaus Journal: GMS Hyg Infect Control Date: 2016-04-21
Authors: Christian Berg; Mette M Rosenkilde; Thomas Benfield; Lene Nielsen; Thomas Sundelin; Hans R Lüttichau Journal: BMC Infect Dis Date: 2021-04-26 Impact factor: 3.090
Authors: Witold Lewandowski; Carla Talarico; Karen Fowler; Jacek Mucha; Monika Neumann; Magdalena Kaczanowska; Maciej Grys; Elvira Schmidt; Andrew Natenshon; Philip O Buck; John Diaz-Decaro Journal: BMC Public Health Date: 2022-09-01 Impact factor: 4.135
Authors: Hsuan-Yuan Wang; Sarah M Valencia; Susanne P Pfeifer; Jeffrey D Jensen; Timothy F Kowalik; Sallie R Permar Journal: Viruses Date: 2021-06-09 Impact factor: 5.818
Authors: Minal M Amin; Jennifer D Stowell; William Hendley; Philip Garcia; D Scott Schmid; Michael J Cannon; Sheila C Dollard Journal: BMC Infect Dis Date: 2018-08-13 Impact factor: 3.090